Food recall: Sugar-free Mixed Berry Gummies Brand Name: Extract Labs Generic Name: Dietary Supplement Strength: 10mg CBD and 10mg D9
Extract Labs, Inc. (Lafayette, CO) initiated this food recall on 26 Aug 2025; FDA lists 4 product records under event 97500, classified Class II.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 54% of the 569 food enforcement events initiated in 2025 carry the same class.
Status: Terminated, terminated 30 Oct 2025. Initiation: voluntary: firm initiated. This is the only enforcement event on this register for Extract Labs, Inc..
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Extract Labs, Inc., Lafayette, CO.
Reason for recall
"Potential peanut protein cross-contact."
Distribution
"Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand."
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| H-0621-2025 | Sugar-free Mixed Berry Gummies Brand Name: Extract Labs Generic Name: Dietary Supplement Strength: 10mg CBD and 10mg D9 THC per gummy Dosage: 1 gummy Form: Gummy Administration: Oral Intended use: Dietary Supplement Type of packaging: 225cc amber packer bottle with child-resistant cap and inner pressure seal Net wt:… | 2180 gummies (109/20 ct bottles) | Class II | Terminated | 1 Oct 2025 |
| H-0622-2025 | Elderberry 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further… | 19,720 gummies | Class II | Terminated | 1 Oct 2025 |
| H-0623-2025 | Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further… | 19,810 gummies | Class II | Terminated | 1 Oct 2025 |
| H-0624-2025 | Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further… | 19,750 gummies | Class II | Terminated | 1 Oct 2025 |
Context
Questions and answers
Why was this food recalled?
FDA's record gives the reason for recall as: "Potential peanut protein cross-contact."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand."
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 30 Oct 2025. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA food enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.